Stocks / NASDAQ / SciClone Pharmaceuticals, Inc.

SciClone Pharmaceuticals, Inc.

Our Opinion

SciClone Pharmaceuticals is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in research and development of some of their therapeutic treatments.

Supporting Evidence:

The company announced in the following press release that they conduct pre-clinical trials of their drugs on animals.

“Experimental data and clinical results derived from studies with animals or a limited group of patients may not be predictive of the results of larger studies and, therefore, such experimental or clinical data is not necessarily predictive of efficacy or safety or the results of larger studies and clinical trials.” Read the following article

Company Description

SciClone Pharmaceuticals, Inc. engages in the development of therapeutics treatment for cancer, infectious diseases, and cardiovascular disorders. Its product portforlio includes ZADAXIN, Holxan, Mesna, Endoxan, Farlutal, Methotrexate. Estracyt, Neucardin, Loramyc, and DC Bead. [Source: MarketWatch]

Company Website: